Biotech Business - June 29, 2026
Cantargia announces outcome in rights issue
The board of directors of Cantargia has announced the outcome of the rights issue of shares that was announced on 28 May 2026.
Financing - June 19, 2026
Qlucore receives approval for EUR 0.5 million EU payment
Qlucore has received approval for a third payment of approximately EUR 0.5 million under its previously awarded EU grant. The total grant amounts to EUR 2.5 million and is distributed across four installments.
Biotech Business - June 18, 2026
Medivir has completed a directed share issue of approx SEK 140 million
The Directed Share Issue was oversubscribed and included both new and existing investors, including Cicero Fonder, Storebrand Sverige Plus and Storebrand Sverige Småbolag Plus as well as Hallberg Management AB, Carl Bennet AB, LINC AB, and Nordea Småbolagsfond Norden.
Biotech Business - June 17, 2026
Alvotech announces USD 152 million share offering
Alvotech has announced the pricing of its previously announced underwritten public offering of 22,666,667 of its ordinary shares at an offering price of USD 3.75 per share.
Biotech Business - June 16, 2026
CEPI extends support for Abera’s development of the BERA vaccine platform
Abera Bioscience has announces that CEPI (Coalition for Epidemic Preparedness Innovations) has decided to extend the ongoing project supporting the development of Abera’s BERA vaccine platform and the company’s innovative influenza vaccine candidate.
Biotech Business - June 4, 2026
Haga Bioscience raises USD 2.3 million
The Swedish spatial biology startup Haga Bioscience has closed a USD 2.3 million oversubscribed seed financing round bringing total funding, including pre-seed financing, to approximately USD 3 million.
